E
Elias Anaissie
Researcher at University of Cincinnati
Publications - 373
Citations - 45035
Elias Anaissie is an academic researcher from University of Cincinnati. The author has contributed to research in topics: Transplantation & Multiple myeloma. The author has an hindex of 107, co-authored 372 publications receiving 42808 citations. Previous affiliations of Elias Anaissie include Pennsylvania State University & Celgene.
Papers
More filters
Journal ArticleDOI
Antitumor activity of thalidomide in refractory multiple myeloma.
Seema Singhal,Jayesh Mehta,Raman Desikan,D Ayers,Paula K. Roberson,Paul Eddlemon,Nikhil C. Munshi,Elias Anaissie,Carla S. Wilson,Madhav V. Dhodapkar,J Zeddis,Bart Barlogie +11 more
TL;DR: Thalidomide can induce marked and durable responses in some patients with multiple myeloma, including those who relapse after high-dose chemotherapy, and is active against advancedMyeloma.
Journal ArticleDOI
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Thomas J. Walsh,Elias Anaissie,David W. Denning,Raoul Herbrecht,Dimitrios P. Kontoyiannis,Kieren A. Marr,Vicki A. Morrison,Vicki A. Morrison,Brahm H. Segal,William J. Steinbach,David A. Stevens,David A. Stevens,Jo Anne H. Van Burik,John R. Wingard,Thomas F. Patterson +14 more
TL;DR: This research presents a novel, scalable, scalable and scalable approach that allows for real-time evaluation of the impact of Epstein-Barr virus on the development and management of childhood cancer in rats.
Journal ArticleDOI
Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)
Peter G. Pappas,Barbara D. Alexander,David R. Andes,Susan Hadley,Carol A. Kauffman,Alison G. Freifeld,Elias Anaissie,Lisa Brumble,Loreen A. Herwaldt,James Lto,Dimitrios P. Kontoyiannis,G. Marshall Lyon,Kieren A. Marr,Vicki A. Morrison,Benjamin J. Park,Thomas F. Patterson,Trish M. Perl,Robert A. Oster,Mindy G. Schuster,Randall C. Walker,Thomas J. Walsh,Kathleen A. Wannemuehler,Tom M. Chiller +22 more
TL;DR: Transplant-Associated Infection Surveillance Network data provide important insights into the timing and incidence of IFIs among organ transplant recipients, which can help to focus effective prevention and treatment strategies.
Journal ArticleDOI
Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database
Dimitrios P. Kontoyiennis,Kieren A. Marr,Benjamin J. Park,Barbara D. Alexander,Elias Anaissie,Thomas J. Walsh,James I. Ito,David R. Andes,John W. Baddley,Janice M. Brown,Lisa Brumble,Alison G. Freifeld,Susan Hadley,Loreen A. Herwaldt,Carol A. Kauffman,Katherine M. Knapp,G. Marshall Lyon,Vicki A. Morrison,Genovefa A. Papanicolaou,Thomas F. Patterson,Trish M. Perl,Mindy G. Schuster,Randall C. Walker,Kathleen A. Wannemuehler,John R. Wingard,Tom M. Chiller,Peter G. Pappas +26 more
TL;DR: In this national prospective surveillance study of IFIs in HSCT recipients, the cumulative incidence was highest for aspergillosis, followed by candidiasis, and understanding the epidemiologic trends and burden of IFI may lead to improved management strategies and study design.
Journal ArticleDOI
The molecular classification of multiple myeloma
Fenghuang Zhan,Yongsheng Huang,Yongsheng Huang,Simona Colla,Simona Colla,James P. Stewart,James P. Stewart,Ichiro Hanamura,Ichiro Hanamura,Sushil K. Gupta,Sushil K. Gupta,Joshua Epstein,Joshua Epstein,Shmuel Yaccoby,Shmuel Yaccoby,Jeffrey R. Sawyer,Jeffrey R. Sawyer,Bart Burington,Bart Burington,Elias Anaissie,Elias Anaissie,Klaus Hollmig,Klaus Hollmig,Mauricio Pineda-Roman,Mauricio Pineda-Roman,Guido J Tricot,Guido J Tricot,Frits van Rhee,Frits van Rhee,Ronald Walker,Ronald Walker,Maurizio Zangari,Maurizio Zangari,John Crowley,John Crowley,Bart Barlogie,Bart Barlogie,John D. Shaughnessy +37 more
TL;DR: A subset of cases with a predominating myeloid gene expression signature had more favorable baseline characteristics and superior prognosis to those lacking this signature, suggesting that this signature is linked to disease progression.